✦ LIBER ✦

Central Nervous System Blast Crisis in Chronic Myeloid Leukemia on Imatinib Mesylate Therapy: Report of Two Cases

✍ Scribed by Narayan Radhika; Mishra Minakshi; Mohanty Rajesh; Baisakh R. Manas; Mishra Deepak Kumar

Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 214 KB
Volume: 27
Category: Article
ISSN: 0971-4502
DOI: 10.1007/s12288-011-0055-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Central nervous system blastic crisis in

Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report

✍ Abdullah Altintas; Timucin Cil; Ilhan Kilinc; Muhammet Ali Kaplan; Orhan Ayyildi 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 165 KB

Prophylaxis of central nervous system le

Prophylaxis of central nervous system leukemia: a case of chronic myeloid leukemia with lymphoid blast crisis treated with imatinib mesylate

✍ Vasantha Thavaraj; Rachna Seth 📂 Article 📅 2008 🏛 SP Children’s Hospital, Zhejiang University School 🌐 English ⚖ 86 KB

Imatinib mesylate-sensitive blast crisis

Imatinib mesylate-sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: Report of two cases

✍ Takehiro Higashi; Junichi Tsukada; Chiaki Kato; Atsushi Iwashige; Takamitsu Mizo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

Is it possible to discontinue imatinib m

Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature

✍ Salvatore Guastafierro; Umberto Falcone; Maria Celentano; Milena Coppola; Maria 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Imatinib mesylate (IM) therapy leads to a complete cytogenetic response (CCyR) in 75-90% of Chronic Myeloid Leukemia (CML) patients in chronic phase, but only a small percentage of patients achieve complete molecular response (CMR). Very little is known about IM discontinuation. We report the case o